|
2025
|
Invention
|
Benzamide compounds for treatment of herpes viruses. The present disclosure provides, in part, no... |
|
|
Invention
|
Bicyclic heterocycle compounds for treatment of herpes viruses. The present disclosure provides b... |
|
|
Invention
|
Pharmaceutical compositions for herpes virus. The present invention relates to methods and compos... |
|
2024
|
Invention
|
Imidazo[1,2-a][1,8]naphthyridine derivatives as enhancers of innate immune response for the treat... |
|
|
Invention
|
Azetidine compounds for treatment of hsv. The present disclosure provides, in part, azetidine com... |
|
|
Invention
|
A crystalline form of 2-(3-(2,,5'-difluoro-[1,1'-biphenyl]-4-yl)-2-oxotetrahydropyrimidin-1(2h)-y... |
|
|
Invention
|
Benzothia(dia)zepine compounds for treatment of hbv and hdv. The present disclosure provides, in ... |
|
|
Invention
|
Oral pharmaceutical compositions. The present invention relates to methods and compositions for t... |
|
2023
|
Invention
|
Hepatitis b core protein modulators.
The present disclosure provides, in part, compounds having ... |
|
|
Invention
|
Bicyclic heterocycle compounds for treatment of herpes viruses. The present disclosure provides, ... |
|
|
Invention
|
Cyclic urea thiazolyl compounds for treatment of hsv. The present disclosure provides, in part, c... |
|
|
Invention
|
A novel crystalline form of pritelivir. The invention relates to a novel crystalline form of prit... |
|
|
Invention
|
2-(imidazo[1, 2-a]1,8-naphthyridin-8-yl)-1,3,4-oxadiazole derivatives as enhancers of innate immu... |
|
|
Invention
|
Benzothia(dia)zepine compounds for treatment of hbv and hdv.
The present disclosure provides, in... |
|
2022
|
Invention
|
Pharmaceutical compositions for the treatment of hbv. The present invention relates pharmaceutica... |
|
|
Invention
|
Crystalline forms of a 5-aminopyrazole compound useful for treating hbv. The present disclosure p... |
|
|
Invention
|
5-membered heteroaryl carboxamide compounds for treatment of hbv. The present disclosure provides... |
|
|
Invention
|
Process.
The present disclosure generally relates to methods of synthesizing compounds useful as... |
|
|
Invention
|
Novel crystalline forms.
The present disclosure generally relates to novel crystalline forms of ... |
|
|
Invention
|
Novel crystalline forms. The present disclosure generally relates to novel crystalline forms of a... |
|
|
Invention
|
Process. The present disclosure generally relates to methods of synthesizing compounds useful as ... |
|
2021
|
Invention
|
Pyrazole carboxamide compounds for treatment of hbv.
The present disclosure provides, in part, p... |
|
|
Invention
|
5-membered heteroaryl carboxamide compounds for treatment of hbv.
The present disclosure provide... |
|
|
Invention
|
Pyrazole carboxamide compounds for treatment of hbv. The present disclosure provides, in part, py... |
|
|
Invention
|
Hepatitis b core protein allosteric modulators.
The present disclosure provides, in part, compou... |
|
|
Invention
|
Cyclic sulfamide compounds and methods of using same.
The present disclosure provides, in part, ... |
|
|
Invention
|
Process for making hepatitis b core protein modulators.
The present disclosure provides, in part... |
|
|
Invention
|
Hepatitis b core protein modulators. The present disclosure provides, in part, compounds having a... |
|
2020
|
Invention
|
Compositions comprising bacterial species and methods related thereto. Alistipes, e.g.Alistipes s... |
|
|
Invention
|
Compositions comprising bacterial species and methods related thereto. The disclosure relates gen... |
|
|
Invention
|
Compositions comprising bacterial species and methods related thereto. Collinsella, e.g.,Collinse... |
|
|
Invention
|
Pharmaceutical compositions for the treatment of hbv.
The present disclosure provides, in part, ... |
|
2019
|
Invention
|
Cyclic sulfamide compounds for treatment of hbv.
The present disclosure provides, in part, cycli... |
